Drawing for STRESSMATE

USPTO serial 97291384

STRESSMATE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
DAVIS, TRENTON MICHAEL
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with STRESSMATE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Paul Oleksiuk

John Paul Oleksiuk COOLEY LLP1299 PENNSYLVANIA AVENUE, NW, SUITE 700WASHINGTON, DC 20004United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable mobile applications for tracking patient symptoms, aiding patients in symptom prevention, and helping patients manage their diseases; downloadable mobile applications for providing access to information and educational resources for patients, providers and researchers related to disease diagnosis, treatment and management; downloadable computer software for tracking patient symptoms, aiding patients in symptom prevention, and helping patients manage their diseases; downloadable computer software for providing access to information and educational resources for patients, providers and researchers related to disease diagnosis, treatment and managementACTIVE—
035General business advertising services, namely, promoting the goods and services of others by disseminating business leads, business information, and information regarding goods and services available for purchase; business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare quality data for business purposes; providing advertising, marketing and promotional services for the healthcare, pharmaceutical, and medical products of othersACTIVE—
042Providing on-line, non-downloadable, internet-based software application for providing access to information and educational resources for patients, providers and researchers related to disease and symptom diagnosis, treatment and management; providing a website featuring on-line non-downloadable software for providing access to information and educational resources for patients, providers and researchers related to disease and symptom diagnosis, treatment and management; software as a service (SaaS) services, namely, hosting software for use by others for providing access to information and educational resources for patients, providers and researchers related to disease and symptom diagnosis, treatment and management; software as a service (SaaS) services featuring software for providing access to information and educational resources for patients, providers and researchers related to disease and symptom diagnosis, treatment and managementACTIVE—
044Providing a resource website featuring information in the field of health; web-based health assessment services, namely, a series of health-related questions for response from the user that result in a report that provides health-related information in the form of recommended educational resources and treatment informationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 8, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 8, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 10, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 8, 2023EX1GSOU EXTENSION 1 GRANTED—
Aug 8, 2023EXT1SOU EXTENSION 1 FILED—
Aug 8, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 7, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 10, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 10, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 21, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 8, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 8, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Dec 8, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 8, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 8, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 6, 2022DOCKASSIGNED TO EXAMINER—
Mar 7, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 5, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance